September 30, 2019 — A biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
September 30, 2019
September 30, 2019 – Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy ...
September 30, 2019
September 27, 2019 — Ancora Heart Inc. announced results from an interim analysis of heart failure patients treated in ...
September 27, 2019
September 26, 2019 — New data from the Phase IV independent TWILIGHT trial showed Brilinta (ticagrelor) monotherapy redu ...
September 26, 2019
September 25, 2019 – Cardiac magnetic resonance imaging (MRI) analysis can be performed significantly faster with ...
September 25, 2019
September 25, 2019 — Ten-year survival rates are similar for bypass surgery and coronary stenting with drug-eluting ...
September 25, 2019
There was a 77 percent increase in survival in cardiogenic shock patients treated using a new protocol in the National ...
September 22, 2019
September 20, 2019 — Low-dose aspirin does not prolong disability-free survival of healthy people over 70, even in those ...
September 20, 2019
September 18, 2019 — Early use of an implantable cardioverter-defibrillator (ICD) after primary coronary intervention ...
September 18, 2019
September 18, 2019 — Discharge of patients with suspected acute coronary syndromes under a 0- and 1-hour high ...
September 18, 2019
September 17, 2019 — Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically ...
September 17, 2019
September 12, 2019 — Corvia Medical has sponsored and is actively enrolling patients in a heart failure (HF) device ...
September 12, 2019
September 11, 2019 — Percutaneous reduction of secondary mitral regurgitation in patients with heart failure does not ...
September 11, 2019
September 11, 2019 — The ever-present devices that seem to track all our moves can be annoying, intrusive or worse, but ...
September 11, 2019
September 11, 2019 — The angiotensin neprilysin inhibitor sacubitril/valsartan (Entresto) missed its primary endpoint of ...
September 11, 2019